Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Airway infection

M Niroumand1, R F Grossman

  • 1Division of Respiratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

Infectious Disease Clinics of North America
|October 21, 1998
PubMed
Summary
This summary is machine-generated.

Effective bronchitis management involves smoking cessation and vaccinations to prevent exacerbations. Stratifying patients helps guide antibiotic selection, reducing treatment failures and healthcare costs for acute flares.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etiological diagnosis of pneumonia: A goal worth pursuing?

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Concentrations of krypton-85 near the Nevada Test Site.

Environmental science & technology·2012
Same author

Out-patient management of patients with chronic obstructive lung disease.

Canadian family physician Medecin de famille canadien·2011
Same author

Management of chronic bronchitis and acute exacerbations of chronic bronchitis.

International journal of antimicrobial agents·2008
Same author

Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2007
Same author

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus.

European journal of cancer (Oxford, England : 1990)·2006
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Health Economics

Background:

  • Bronchitis, acute and chronic, is a leading cause of physician visits, incurring substantial healthcare costs, work absenteeism, and mortality.
  • Smoking and recurrent respiratory infections are primary risk factors for chronic bronchitis, emphasizing prevention through cessation and vaccination.
  • Bacterial infections frequently trigger acute exacerbations, with routine antibiotic therapy often failing and increasing overall costs.

Purpose of the Study:

  • To review current management strategies for acute and chronic bronchitis, focusing on reducing exacerbations and treatment failures.
  • To highlight the importance of smoking cessation and vaccination in disease management.
  • To discuss the role of patient stratification in optimizing antimicrobial selection for acute bacterial exacerbations.

Related Experiment Videos

Main Methods:

  • Literature review of studies on bronchitis pathogenesis, risk factors, and treatment outcomes.
  • Analysis of existing patient stratification schemes for guiding antimicrobial therapy.
  • Discussion of the impact of treatment failures on medical and economic implications.

Main Results:

  • Smoking cessation and vaccination are crucial for halting chronic bronchitis progression and reducing exacerbation frequency.
  • Patient stratification based on age, disease severity, exacerbation frequency, and comorbidities can predict pathogens and guide antimicrobial choice.
  • Optimized antimicrobial selection may reduce treatment failures, leading to significant medical and economic benefits.

Conclusions:

  • Targeted management strategies, including smoking cessation, vaccination, and risk-stratified antimicrobial selection, are essential for effective bronchitis care.
  • Further research into airway inflammation, infection pathogenesis, and novel antimicrobial agents is needed to improve early and effective treatment for high-risk patients.